Clinical Trial Update: Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial of INS365 Ophthalmic Solution for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• INS365 Ophthalmic Solution (INS365)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED